Shuttle Pharmaceuticals News

Express News | Shuttle Pharmaceuticals Q1 EPS $(0.10) Down From $(0.07) YoY

BenzingaMay 14 09:11 ET

Express News | Shuttle Pharmaceuticals Holdings Inc - We Expect to Have 'first Patient, First Dose' in Q2 of 2024

ReutersMay 14 09:02 ET

Express News | Shuttle Pharma Provides First Quarter 2024 Corporate Update

ReutersMay 14 09:00 ET

Shuttle Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 17:08 ET · Announcements

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

GAITHERSBURG, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer

GlobeNewswireApr 23 16:15 ET

Shuttle Pharmaceuticals Files to Sell Subscription Rights to Buy $4.5M in Units

Seeking AlphaApr 5 17:27 ET

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Globe NewswireApr 3 09:00 ET

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Yahoo FinanceApr 3 07:00 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha

BenzingaMar 22 17:33 ET

Express News | Shuttle Pharmaceuticals Q4 EPS $(0.11) Down From $(0.06) YoY

Moomoo 24/7Mar 22 09:00 ET

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused...

PR NewswireMar 22 09:00 ET

Express News | Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"

Moomoo 24/7Mar 18 11:02 ET

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Webcast presentation to take place at 11:25am ETROCKVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty

GlobeNewswireMar 5 09:00 ET

Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now

Yahoo FinanceMar 5 07:00 ET

Shuttle Pharmaceuticals to Launch $4.5 Million Rights Offering

InvestingFeb 13 08:42 ET

Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding

TipRanksFeb 13 08:13 ET

Shuttle Pharmaceuticals Bolsters Investor Relations With New Partnership

TipRanksFeb 6 04:55 ET

Shuttle Pharmaceuticals Acquires Promising Prostate Cancer Technology

TipRanksFeb 6 04:55 ET

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the...

PR NewswireJan 23 16:30 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersSagimet Biosciences (NASDAQ:SGMT) stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved up

BenzingaJan 22 12:31 ET